Leonardo Maestri Teixeria

Co-founder Geneweave

Leonardo Teixeira is a co-founder of Endpoint Health, a precision medicine startup focused in intensive care. Prior to founding Endpoint Health, Leo was a Research Director at Roche Diagnostics, where he led the Research and early development of the next-generation platform from GeneWEAVE biosciences after the acquisition by Roche. Leo Co-Founded GeneWEAVE Biosciences, an IVD company focused on creating diagnostic systems to rapidly detect and guide antibiotic selection for serious infections. GeneWEAVE raised a total of $25M and was acquired by Roche in 2015 in a deal valued at $425M USD.

Leo received his B.S. and M.S. from Universidade Federal de Vicosa in Brazil, and his PhD from Cornell University.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search